The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Open accessAbstract
Heterozygous mutations in the gene encoding isocitrate dehydrogenase-1 ( IDH1 ) occur in certain human brain tumors, but their mechanistic role in tumor development is unknown. We have shown that tumor-derived IDH1 mutations impair the enzyme's affinity for its substrate and dominantly inhibit wild-type IDH1 activity through the formation of catalytically inactive heterodimers. Forced expression of mutant IDH1 in cultured cells reduces formation of the enzyme product, α-ketoglutarate (α-KG), and increases the levels of hypoxia-inducible factor subunit HIF-1α, a transcription factor that facilitates tumor growth when oxygen is low and whose stability is regulated by α-KG. The rise in HIF-1α levels was reversible by an α-KG derivative. HIF-1α levels were higher in human gliomas harboring an IDH1 mutation than in tumors without a mutation. Thus, IDH1 appears to function as a tumor suppressor that, when mutationally inactivated, contributes to tumorigenesis in part through induction of the HIF-1 pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HIF is stabilized in IDH-associated gliomas; this has been proposed to be a consequence of intracellular depletion of 2OG following IDH loss of function (Zhao et al, 2009).”
From The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases (2011) · cites this paper as Zhao et al, 2009
In the citing paper
“The IDH mutations occur at substrate-binding arginine residues (Arg 132 in IDH1; Arg 140 and Arg 172 in IDH2) and inactivate IDH for conversion of isocitrate to 2-oxoglutarate (2OG; Zhao et al, 2009).”
From The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases (2011) · cites this paper as Zhao et al, 2009
In the citing paper
“Overexpression of IDH1 Arg 132 mutants results in elevated HIFa levels (Zhao et al, 2009).”
From The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases (2011) · cites this paper as Zhao et al, 2009
In the citing paper
“The stability of HIF‐1α is regulated by α‐KG, and increasing α‐KG reduces the expression of HIF‐1α.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [168]
In the citing paper
“Inhibiting the mitochondrial enzyme SDH during ischaemia by preloading tissues with the SDH inhibitor DMM prevented succinate accumulation during ischaemia and protected against tissue damage upon reperfusion150.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [150]
In the citing paper
“succinate accumulated during ischaemia and is then oxidised upon reperfusion to drive the mitochondrial superoxide formation that contributes to ischaemia-reperfusion (IR) injury150,151.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [150]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
Analysis of the IDH1 codon 132 mutation in brain tumors
Balss, J., Meyer, J., Mueller, W., Korshunov, A., Hartmann, C., & von Deimling, A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0455-2 · Cited by 1,036
Xu, X., Zhao, J., Xu, Z., Peng, B., Huang, Q., Arnold, E., & Ding, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404298200 · Cited by 407
Self-citationBleeker, F. E., Lamba, S., Leenstra, S., Troost, D., Hulsebos, T. J. M., Vandertop, W. P., Frattini, M., Molinari, F., Knowles, M. A., Cerrato, A., et al. (2009) · Human Mutation · doi:10.1002/humu.20937 · Cited by 365
Evaluation of HIF-1 inhibitors as anticancer agents
Semenza, G. L. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.08.006 · Cited by 363
MacKenzie, E. D., Selak, M. A., Tennant, D. A., Payne, L. J., Crosby, S., Frederiksen, C. M., Watson, D. G., & Gottlieb, E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01927-06 · Cited by 359
Cellular concentrations of enzymes and their substrates
Albe, K. R., Butler, M. H., & Wright, B. E. (1990) · Journal of Theoretical Biology · doi:10.1016/s0022-5193(05)80266-8 · Cited by 318
Multiple NADPH-producing pathways control glutathione (GSH) content in retina
Winkler, B. S., Desantis, N. M., & Solomon, F. (1986) · Experimental Eye Research · doi:10.1016/s0014-4835(86)80013-6 · Cited by 107
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–999 of 999
R132 mutations in canine isocitrate dehydrogenase 1 (IDH1) lead to functional changes
Kawakami, S., Ochiai, K., Azakami, D., Kato, Y., Michishita, M., Morimatsu, M., Ishiguro‐Oonuma, T., Onozawa, E., Watanabe, M., & Omi, T. (2017) · Veterinary Research Communications · doi:10.1007/s11259-017-9707-8 · Cited by 5
Anomalies génétiques et moléculaires des glioblastomes (GBM)
Larsen, C. (2010) · Bulletin du Cancer · doi:10.1684/bdc.2010.1215 · Cited by 5
Arteriovenous malformation within an isocitrate dehydrogenase 1 mutated anaplastic oligodendroglioma
Chen, C., Lai, G. P., Muller, K., & Carter, B. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.159373 · Cited by 5
Metabolic Analysis of Drosophila melanogaster Larval and Adult Brains
Neville, K. E., Bosse, T. L., Klekos, M., Mills, J. F., & Tipping, M. (2018) · Journal of Visualized Experiments · doi:10.3791/58007 · Cited by 4
A niche-dependent redox rheostat regulates epithelial stem cell fate
Chen, X., Raghunathan, K., Bao, B., Ngwa, E. M., Kwong, A., Wu, Z., Babcock, S. J., Baek, C., Ye, G., Muppirala, A. N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66636-5 · Cited by 4
Peng, G., Yu, Y., Chen, X., & Huang, H. (2020) · International Journal of Analytical Chemistry · doi:10.1155/2020/4901761 · Cited by 4
Targeted therapies in advanced biliary malignancies: a clinical review
Grewal, U. S., Gaddam, S. J., Beg, M. S., & Brown, T. J. (2024) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2024.2387612 · Cited by 4
Brain Tumor Metabolism — Unraveling Its Role in Finding New Therapeutic Targets
Miranda‐Gonçalves, V., Baltazar, F., & Reis, R. M. (2015) · InTech eBooks · doi:10.5772/59606 · Cited by 5
Screening forIDHmutations in chronic myelomonocytic leukemia
Ibáñez, M., Such, E., Cervera, J., Luna, I., Gómez‐Seguí, I., López‐Pavía, M., Avaría, A., Senent, M. L., Sanz, G. F., & Sanz, M. Á. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.701295 · Cited by 4
Genetic Alterations of Glioblastoma
Richterová, R., & Kolarovszki, B. (2016) · InTech eBooks · doi:10.5772/63127 · Cited by 7
Song, P., Li, S., Wu, Y., Lv, C., Wang, P., & Zhu, G. (2016) · Journal of Basic Microbiology · doi:10.1002/jobm.201600096 · Cited by 4
Self-citationWiehle, L., Raddatz, G., Pusch, S., Gutekunst, J., von Deimling, A., Rodríguez‐Paredes, M., & Lyko, F. (2017) · Cell Stress · doi:10.15698/cst2017.10.106 · Cited by 4
Zhou, X., Zheng, M., Zhao, N., Hu, Y., Yang, K., Huo, J., Liu, G., Huang, J., Chen, L., Zhou, Y., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105569 · Cited by 4
The immune regulation of BCL3 in glioblastoma with mutated IDH1
Fan, S., Wu, N., Chang, S.-C., Chen, L., & Sun, X. (2022) · Aging · doi:10.18632/aging.204048 · Cited by 4
Thomas, T., Thakur, S. B., & Young, R. J. (2023) · BJR|Open · doi:10.1259/bjro.20210070 · Cited by 6
Novel germline SDHD deletion associated with an unusual sympathetic head and neck paraganglioma
Cadiñanos, J., Llorente, J. L., Rosa, J. D. L., Villameytide, J. A., Illán, R., Sánchez-Durán, N., Murías, E., & Cabanillas, R. (2010) · Head & Neck · doi:10.1002/hed.21384 · Cited by 4
Classification of Primary Brain Tumors: Molecular Aspects
Molnár, P. (2011) · InTech eBooks · doi:10.5772/22484 · Cited by 4
Current and future directions for Phase II trials in high-grade glioma
Alexander, B. M., Lee, E. Q., Reardon, D. A., & Wen, P. Y. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.158 · Cited by 4
Metabolic Syndromes and Malignant Transformation: Where the Twain Shall Meet
Bhagwat, N., & Levine, R. L. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001669 · Cited by 4
Cilengitide in bevacizumab-refractory high-grade glioma
Lombardi, G., Zustovich, F., Farina, P., Polo, V., Farina, M., Puppa, A. D., Bertorelle, R., Gardiman, M. P., Berti, F., & Zagonel, V. (2012) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283520e2c · Cited by 4
Wang, H., Wang, X., Xu, L., & Zhang, J. (2023) · World Neurosurgery · doi:10.1016/j.wneu.2023.05.109 · Cited by 3
Roh, Y. H., Cheong, E., Park, J. E., Choi, Y., Jung, S. C., Song, S. W., Kim, Y., Hong, C., Kim, J. H., & Kim, H. S. (2025) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.29781 · Cited by 3
Pan, X.-H., Lan, B., Wang, N., Su, J., & Gao, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115970 · Cited by 3
Isocitrate Dehydrogenase Mutations in Cancer: From Bench to Bedside Applications
Fang, Y., Wang, X., Luo, K., Dakal, T. C., Bai, H., Xu, C., & Zhang, G. (2026) · MedComm · doi:10.1002/mco2.70732 · Cited by 5
Sun, L., 杨汉丰, Cao, Z., Yang, D., Du, N., Lu, Y., Yan, M., Li, J., Shi, F., Zhou, X., et al. (2026) · BMC Medical Imaging · doi:10.1186/s12880-026-02396-y · Cited by 3
Xu, H., Cao, Y. W., Ruan, J., Wang, F., He, Y., Yang, L., Tian, Y., Du, F., Zhang, N., & Cao, X. (2024) · Journal of Neuro-Oncology · doi:10.1007/s11060-024-04789-x · Cited by 3
Prevalence of SPOP and IDH Gene Mutations in Prostate Cancer in a Jordanian Population
Alorjani, M. S., Bashir, S. M. A., Al-Zaareer, B., Al-Khatib, S., Al‐Zoubi, R. M., Al‐Trad, B., Alarjah, M. I. A., Alzu’bi, A., Al-Hamad, M., Al‐Batayneh, K., et al. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10974-4 · Cited by 3
Nakagawa, M., Shimada, E., Guardino, N. J., Miyamoto, R., Puviindran, V., Peairs, E. M., Matarangas, A., Ishikawa, K., Nguyen, T., Browne, M. R., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2501519122 · Cited by 3
Tumor Cell Complexity and Metabolic Flexibility in Tumorigenesis and Metastasis
Berridge, M. V., & Herst, P. M. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1824-5_2 · Cited by 3
Hussein, K., Engelhardt, B. M., Kreipe, H. H., & Bock, O. (2010) · Blood · doi:10.1182/blood-2010-06-290791 · Cited by 3
Peroxireduxin-4 is Over-Expressed in Colon Cancer and its Down-Regulation Leads to Apoptosis
Leydold, S. M., Seewald, M. J., Stratowa, C., Kaserer, K., Sommergruber, W., Kraut, N., & Schweifer, N. (2011) · Cancer Growth and Metastasis · doi:10.4137/cgm.s6584 · Cited by 4
Hossain, M. S. (2014) · American Journal of BioScience · doi:10.11648/j.ajbio.20140206.16 · Cited by 3
A Survey of the Neuro-Oncology Landscape
Lukas, R. V., Wu, J., Dey, M., Buerki, R. A., Byrne, R. W., & Dohrmann, G. J. (2018) · Journal of Clinical Neurology · doi:10.3988/jcn.2018.14.1.8 · Cited by 3
Novel canine isocitrate dehydrogenase 1 mutation Y208C attenuates dimerization ability
Kawakami, S., Michishita, M., Sakaue, M., Morimatsu, M., Uemura, M., Kashiwagi, N., Maeda, M., Machida, Y., Azakami, D., Egusa, A. S., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.12214 · Cited by 3
Jafari, S. H., Rabiei, N., Taghizadieh, M., Mirazimi, S. M. A., Kowsari, H., Farzin, M. A., Bahabadi, Z. R., Rezaei, S., Mohammadi, A. H., Alirezaei, Z., et al. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153528 · Cited by 3
Gho, D. S., & Cooper, R. M. (2021) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002375 · Cited by 3
Ivosidenib for the treatment of relapsed or refractory acute myeloid leukemia with an IDH1 mutation
Pasquier, F., Chahine, C., Marzac, C., & de Botton, S. (2020) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2020.1792286 · Cited by 3
Molecular Pathology and Diagnostics of Gliomas
Kresak, J. L., & Shan, Y. (2013) · Springer eBooks · doi:10.1007/978-94-007-7192-5_1 · Cited by 3
The Role of Isocitrate Dehydrogenase Mutations in Glioma Brain Tumors
Chang, C.-M., Xu, K., & Hui-Kuo, G. (2011) · InTech eBooks · doi:10.5772/23238 · Cited by 3
Genetic Alterations and Their Clinical Implications in Acute Myeloid Leukemia
Hou, H., Chou, W., & Tie, H.-F. (2011) · InTech eBooks · doi:10.5772/26421 · Cited by 4
Imaging Markers of Isocitrate Dehydrogenase-1 Mutations in Gliomas
Price, S. J. (2015) · Neurosurgery · doi:10.1227/neu.0000000000000812 · Cited by 3
Research Progress on Bioenergy Metabolic Mechanism of Cancer*
Luo, X., & Ya, C. (2011) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2010.00611 · Cited by 3
Kälin, S., & Kälin, R. E. (2016) · Energy balance and cancer · doi:10.1007/978-3-319-41677-9_7 · Cited by 3
Chance Favors the Perplexed Mind: The Critical Role of Mechanistic Biochemistry in Drug Discovery
Copeland, R. A. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00345 · Cited by 3
Alghamri, M. S., Avvari, R., Thalla, R., Kamran, N., Zhang, L., Ventosa, M., Taher, A. W., Faisal, S. M., Núñez, F. J., Garcia-Fabiani, M. B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.22.215954 · Cited by 3
Mediterranean Pattern Diet in Multiple Sclerosis: A Review Focusing on Immunometabolites
Papiri, G., Paci, C., D’Andreamatteo, G., Membrino, V., Crescenzo, T. D., Cacchiò, G., Cagnetti, C., & Vignini, A. (2025) · Current Neuropharmacology · doi:10.2174/011570159x382929250719084728 · Cited by 2
Autopalmitoylation of IDH1-R132H regulates its neomorphic activity in cancer cells
Hu, L., Lin, J., Sun, L., Berezuk, A., Tuttle, K. S., Zhu, X. Q., Seo, H., Dhe‐Paganon, S., Li, P., Sun, Y., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-025-02131-8 · Cited by 3
Ding, J., Jia, S., Meng, R., Wang, X., Wu, X., Weiliang, S. H. E. N., ZHANG, Y., & Zhu, J. (2026) · Advanced Science · doi:10.1002/advs.76310 · Cited by 2
Self-citationMutation des gènes IDH1/IDH2 : un nouveau marqueur pronostique dans les gliomes
Sanson, M., Wang, X. W., Boisselier, B., Labussière, M., Marie, Y., Paris, S., Idbaïh, A., Hoang‐Xuan, K., & Delattre, J. (2010) · Revue Neurologique · doi:10.1016/s0035-3787(10)70010-2 · Cited by 2
HOT mutation screening in human glioblastomas
Krell, D., Mulholland, P. J., Stebbing, J., Tomlinson, I. P. M., & Bardella, C. (2015) · Future Science OA · doi:10.4155/fso.15.20 · Cited by 2
Saavedra, F., Boyarchuk, E., Alvarez, F., Almouzni, G., & Loyola, A. (2019) · RNA technologies · doi:10.1007/978-3-030-14792-1_23 · Cited by 2
Chemical Compounds Targeting DNA Methylation and Hydroxymethylation
Belle, R., Kawamura, A., & Arimondo, P. B. (2019) · Topics in medicinal chemistry · doi:10.1007/7355_2019_76 · Cited by 2
The Distribution and Significance of IDH Mutations in Gliomas
Tran, N. T. N. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.97380 · Cited by 2
Ruoff, F., Kersten, N., Anderle, N., Jerbi, S., Stahl, A., Koch, A., Staebler, A., Hartkopf, A. D., Brucker, S. Y., Hahn, M., et al. (2022) · Cancers · doi:10.3390/cancers14184542 · Cited by 2
Recent findings on molecular alterations in IDH1, TP53, and CASP9 in gliomagenesis
Pua, J. Y., Idris, Z., Yusoff, A. A. M., & Patar, A. (2022) · Biomedical Research and Therapy · doi:10.15419/bmrat.v9i10.775 · Cited by 2
Elmaogod, E. A. A., Daoud, S. A., Mostafa, Z. M., & Mahmoud, E. M. M. (2022) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-022-00325-w · Cited by 2
A big picture of the mitochondria-mediated signals: From mitochondria to organism
Acar, N. V., & Özgül, R. K. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.08.032 · Cited by 2
Mining cancer genomes for change-of-metabolic-function mutations
Tu, K. J., Diplas, B. H., Regal, J. A., Waitkus, M. S., Pirozzi, C. J., & Reitman, Z. J. (2023) · Communications Biology · doi:10.1038/s42003-023-05475-w · Cited by 2
Translational Research Platform for Malignant Central Nervous System Tumors
Tateishi, K. (2024) · Neurologia medico-chirurgica · doi:10.2176/jns-nmc.2024-0078 · Cited by 1
Ali, T. M., Usman, R., Shah, S. A., Parvez, A., Anwar, S., Muneer, Z., & Saeed, M. (2024) · Cancer Control · doi:10.1177/10732748241271714 · Cited by 2
Broome, J. A., Nguyen, N. P., Baumung, C. R. E., Chen, V. C., & Bushnell, E. A. C. (2024) · Biochemistry · doi:10.1021/acs.biochem.4c00022 · Cited by 2
SKP2 ubiquitylation modifies IDH1 to regulate hepatoblastoma cell cycle and glucose metabolism
Yu, P., Li, J., Feng, W., Tao, L., Jia, W., He, Y., & Bi, Y. (2025) · BMC Cancer · doi:10.1186/s12885-025-14644-5 · Cited by 2
Yu, R., Li, X., Zhou, X., Shi, Q., & Tang, H. (2010) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-010-0453-0 · Cited by 2
Kurtz, A., Wenger, R. H., & Eckardt, K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00092-6 · Cited by 2
Neuro-oncology: new hope for patients with gliomas
DeAngelis, L. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70326-6 · Cited by 2
Yu, L., & Qi, S. (2011) · Oncology Letters · doi:10.3892/ol.2011.447 · Cited by 2
Xu, X., Li, Z., & Wen, Z. (2010) · Chinese Journal of Cancer Research · doi:10.1007/s11670-010-0119-3 · Cited by 2
Self-citationIaccarino, C., Nicoli, D., Serra, S., Froio, E., Pisanello, A., Berti, G. D., Ghadirpour, R., Marcello, N., Servadei, F., & Carinci, F. (2011) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320110240s209 · Cited by 2
Hansen, L. J., Diplas, B. H., Becher, O. J., & Yan, H. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588721.002 · Cited by 2
Pathology of Primary Brain Tumors—Gliomas
Wong, D., & Yip, S. S. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811783-5.00006-9 · Cited by 2
Carbonic anhydrase IX as a marker of hypoxia in gliomas: A narrative review
McLendon, R. (2020) · Glioma · doi:10.4103/glioma.glioma_19_20 · Cited by 2
Reactive Oxygen Species and Metabolic Re-Wiring in Acute Leukemias
Robinson, A. J., Darley, R. L., & Tonks, A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94829 · Cited by 2
THE EFFECTS OF METFORMIN ON PANCREATIC CANCER METABOLISM
Cantoria, M. J. (2014) · UA Campus Repository (The University of Arizona) · Cited by 2
Bascur, J. P., Alegría‐Arcos, M., Araya‐Durán, I., Juritz, E., González-Nilo, F. D., & Almonacid, D. E. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/425025 · Cited by 2
Núñez, F. J., Banerjee, K., Mujeeb, A., Mauser, A., Tronrud, C. E., Zhu, Z., Raghuram, S., Sheth, M. R., Agudelo, J. A. P., Zelaya, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.08.584091 · Cited by 2
Rocha, G., Francés‐Gómez, C., Megías, J., Hidalgo, L. M., Casanova, P., Haro-Estevez, J. F., Teruel‐Martí, V., Monleón, D., & San‐Miguel, T. (2025) · Biomedicines · doi:10.3390/biomedicines13071584 · Cited by 1
Biswal, A. S., Nandeshwar, N., Tripathy, U., & Chatterjee, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148571 · Cited by 1
Fujimoto, K., Honda‐Kitahara, M., Hattori, N., Matsushita, Y., Hibiya, Y., Satomi, K., Matsunaga, H., Tsutsumi, S., Okamoto, A., Inoue, T., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-02989-5 · Cited by 1
Discovery of a new binding site and a possible gain in neomorphic activity in R132H_IDH1
Nandeshwar, Biswal, A. S., Chatterjee, S., & Tripathy, U. (2026) · Physical Chemistry Chemical Physics · doi:10.1039/d5cp04261e · Cited by 1
Josephine, A., Kumar, S. A., Varalakshmi, S., & Rajendran, P. (2026) · 3 Biotech · doi:10.1007/s13205-026-04753-8 · Cited by 1
The crosstalk between epigenetics and metabolism in the malignant cell
Țigu, A. B., Ivancuta, A., Constantinescu, C. S., Moisoiu, V., Grăjdieru, O., Cucoreanu, C., Nistor, M., Kegyes, D., Bancos, A., Tomacinschii, V., et al. (2026) · Discover Oncology · doi:10.1007/s12672-026-05082-1 · Cited by 2
Liu, Z., Li, R., Liu, L., Zhang, X., Wang, Y., Li, X., Wang, X., Wu, W., Liu, Y., & Li, P. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c00413 · Cited by 1
Ng, K., Kesari, S., Carter, B. S., & Clark, C. (2011) · InTech eBooks · doi:10.5772/25196 · Cited by 1
Current Insights in the Cellular and Molecular Biology of Chronic Myelomonocytic Leukemia
Itzykson, R., Droin, N. M., & Solary, É. (2012) · International Journal of Hematologic Oncology · doi:10.2217/ijh.12.19 · Cited by 1
Epigenetic Alterations in Glioblastoma Multiforme
Wiencke, J. K. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3345-3_4 · Cited by 1
Expression of IDH1 Mutant Protein R132H and SDHB in Adult and Pediatric Gliomas
Ballester, L. Y., Aung, P. P., Lai, J., Nóbrega, R., Patrocínio, R. M. D. S. V., Wang, Z., Miettinen, M., Warren, K. E., & Qeuzado, M. (2014) · International Journal of Neuropathology · doi:10.7726/ijn.2014.1003 · Cited by 1
New Insights Into Molecular Basis of Glioblastoma Multiforme and Associated Immunosuppression
Dimov, I., Tasić, D., Stefanović, I. B., & Dimov, D. (2012) · AFMN Biomedicine · doi:10.2478/afmnai-2013-0009 · Cited by 1
Isocitrate Dehydrogenase (IDH) Mutation in Gliomas
Chesnelong, C. (2015) · Springer eBooks · doi:10.1007/978-3-319-15811-2_25 · Cited by 1
Lawler, S. E., & Chiocca, E. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382227-7.00065-3 · Cited by 1
The emergence of intracellular metabolite signaling networks
Xu, W., Zhao, J., & Zhao, S. (2016) · IUBMB Life · doi:10.1002/iub.1567 · Cited by 1
Self-citationDico, A. L., Salvatore, D., Diceglie, C., Martelli, C., & Ottobrini, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821567-8.00026-9 · Cited by 1
Wahl, D. R., & Venneti, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-61401-4_6 · Cited by 1
Cholangiocarcinoma: The Present and Future of Targeted Therapies
Kalyan, A., & Shroff, R. T. (2022) · touchREVIEWS in Oncology & Haematology · doi:10.17925/ohr.2022.18.1.9 · Cited by 1
Advances in research on glioma microenvironment and immunotherapeutic targets
Tang, A., Liang, J., Mai, Y., & Sun, H. (2022) · Journal of Cancer Discovery · doi:10.55976/jcd.1202218514-29 · Cited by 1
Bhavya, B., Anand, C. R., Urulangodi, M., Sreelakshmi, K., Deepti, A. N., Menon, G. R., Kesavapisharady, K., Easwer, H. V., & Gopala, S. (2022) · World Academy of Sciences Journal · doi:10.3892/wasj.2022.174 · Cited by 1
Non-canonical approaches to targeting hypoxic tumors.
Zhao, S., & El‐Deiry, W. S. (2022) · PubMed · Cited by 1
Self-citationRole of HIF-1 in Brain Tumor Development
Shahi, M. H. (2023) · Springer eBooks · doi:10.1007/978-981-15-8473-2_13 · Cited by 1
Puviindran, V., Shimada, E., Huang, Z., Ma, X., Ban, G. I., Xiang, Y., Zhang, H., Ou, J., Wei, X., Nakagawa, M., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-76539-y · Cited by 1
Yang, S., Zhu, Z., Chen, Y., Yang, F., Wu, X., Wang, J., Li, W., Yang, W., Song, X., Lu, X., et al. (2024) · Scientia Sinica Chimica · doi:10.1360/ssc-2024-0223 · Cited by 1
Self-citation
Metadata
- Authors
- Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., Ding, J., Lei, Q., Guan, K.-L., & Xiong, Y.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- Molecular and Cell Biology Laboratory, Institute of Biomedical Sciences, Fudan University, 130 Dong-An Road, Shanghai 200032, China.
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Lin, Yan
- Xu, Wei
- Jiang, Wenqing
- Guan, Kun-Liang
- Xiong, Yue
- ORCID
- Venue
- Science
- Published
- 2009-04-10
- Volume
- 324
- Issue
- 5924
- Pages
- 261-265
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3251015
- OpenAlex
- W1964150693
- Cited by
- 1,119
- References
- 12
- Citations by year
- 2026: 24 · 2025: 27 · 2024: 43 · 2023: 36 · 2022: 50 · 2021: 62 · 2020: 58 · 2019: 54 · 2018: 63 · 2017: 71 · 2016: 57 · 2015: 71 · 2014: 74 · 2013: 90 · 2012: 84
- FWCI
- 37.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA068377)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- IDH1 mutation, isocitrate dehydrogenase, glioma, HIF-1α, alpha-ketoglutarate, heterodimer formation, tumor suppressor, hypoxia, carcinogenesis, brain tumors, enzyme activity
- MeSH terms
- Adolescent, Adult, Aged, Astrocytoma, Brain Neoplasms, Cell Line, Child, Female, Glioblastoma, Glioma, Humans, Isocitrate Dehydrogenase, Ketoglutaric Acids, Male, Middle Aged, Oligodendroglioma, Oxalates, Gene Expression Regulation, Neoplastic, Genes, Tumor Suppressor, Mutant Proteins, Hypoxia-Inducible Factor 1, alpha Subunit, Biocatalysis, Protein Multimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
